Moderna’s human trials hopes to justify huge investment

The experimental drug developed by Moderna Technologies is the result of a $5bn investment Pharma groups such as Merck and AstraZeneca have contributed to the development of the drug with over $1bn, with the goal of creating a body that can generate its own medicines, depending on the needs. The project aims to insert artificial […]

Read More